Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03512223
Other study ID # 2017H0244
Secondary ID
Status Recruiting
Phase Early Phase 1
First received
Last updated
Start date October 23, 2018
Est. completion date June 30, 2024

Study information

Verified date September 2023
Source Ohio State University
Contact Alberto Uribe
Phone 6142933559
Email alberto.uribe@osumc.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to evaluate the if the administration of dexamethasone both around the nerve and in the vein (perineural and intravenous (IV)) will prolong the duration of pain relief from ropivacaine when compared with ropivacaine local block alone or when administered along with IV dexamethasone in patients undergoing hand surgery.


Description:

This study aims to evaluate the if the administration of dexamethasone both around the nerve and in the vein (perineural and intravenous (IV)) will prolong the duration of pain relief from ropivacaine when compared with ropivacaine local block alone or when administered along with IV dexamethasone in patients undergoing hand surgery. Individuals who have hand surgery scheduled will be evaluated for eligibility in this study. Eligible and consenting patients will be randomly assigned to one of three groups (1:1:1) as follows: • Group A (IV dexamethasone): Perineural (30ml of 0.75% ropivacaine + 0.5 ml normal saline) and IV (9.0 ml normal saline + 1 ml of 10 mg/ml Dexamethasone) • Group B (IV + perineural dexamethasone): Perineural (30ml of 0.75% ropivacaine + 0.5 ml of 10 mg/ml Dexamethasone) and IV (9.5 ml normal saline + 0.5 ml of 10 mg/ml Dexamethasone) • Group C (control with no adjuvant dexamethasone): Perineural (30ml of 0.75 ropivacaine + 0.5 ml normal saline) and IV (10 ml normal saline) This study is single-blind, so the subjects will not know to which group they have been assigned. All subjects will receive at least a nerve block with a local anesthetic, or numbing agent. After written, informed consent is obtained and on the day of surgery, the research staff will collect information about the subject's medical history including allergies (seasonal and drug related), demographics (gender, age, height, weight), history of drug use, pain and nausea scores, and vital signs. All medication taken 1 month prior to treatment day will be recorded. Information will be collected from the physical examination performed by the surgeon, which is a standard procedure for the pre-operative visit, regardless of participation in the study. After being put under light sedation according to standardized sedation, as written in the protocol, one group will receive a local nerve block and numbing agent. The other two groups will receive either the nerve block and local anesthetic with intravenous dexamethasone or the nerve block and local anesthetic with both intravenous and perineural (local) dexamethasone, as described above. Details regarding the subject's surgery and anesthesia will be collected, and after your surgery, a member of the research team will provide the subject with a diary to document level of pain, movement, any episodes of nausea/vomiting, and the number of pain medicine tablets taken for up to 48 hours after surgery. The subjects will receive a follow up phone call 48 hours after the nerve block from the research team to collect the information already documented in the diary. Thus far, no evidence of dexamethasone toxicity around the nerve has been shown and no neurologic complications or infections have been reported. Only one study reported blood glucose elevations [1]. There is a potential benefit of enhancing the duration of the nerve block and therefore pain management. The results of this study will help clarify if use of dexamethasone as an adjuvant in nerve block will prolong the effect of the nerve block and reduce the heightened sensitivity to pain and burning sensation as the block wears off.


Recruitment information / eligibility

Status Recruiting
Enrollment 108
Est. completion date June 30, 2024
Est. primary completion date June 30, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Adult male and female patients age 18-80 - Undergoing distal radius ORIF (open reduction internal fixation) or CMC (Carpometacarpal) arthroplasty - ASA (American Society of Anesthesiologists) I, II,III - Patients who provide a signed written informed consent - Have a valid phone number and be able to speak, read, and write in English Exclusion Criteria: - Any documented cognitive or psychological disorders that, in the opinion of the principal investigator, can interfere with the patients' pain perception - Diabetes Mellitus - Vulnerable populations: pregnant females, prisoners, breast feeding - Contraindication to nerve block: local infections, bleeding disorders, shoulder deformity, allergy to local anesthetic or dexamethasone - Severe lung disease, known contralateral phrenic nerve injury - Previous history of chronic pain diseases requiring consistent analgesic therapy for at least 1 month prior to surgery - Presence of any medical condition that, in the opinion of the principal investigator, should exclude the patient from the study - BMI = 40 kg/m2

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Dexamethasone
Intravenous and Perineural Dexamethasone for Brachial Plexus Block

Locations

Country Name City State
United States The Ohio State University Wexner Medical Center Columbus Ohio

Sponsors (1)

Lead Sponsor Collaborator
Ohio State University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Duration of anesthetic blockade • The duration of anesthetic blockade measured by the time from performing the perineural block to the first reported pain at the surgical site between groups 48 hours
Secondary Duration of motor block • To compare the duration of motor block between groups (defined as the time between performance of the perineural block and full return of motor function in comparison to the contralateral limb) 48 hours
Secondary Patient satisfaction on a scale of 0-10 (0=not satisfied at all 10=very satisfied) of pain management • To compare overall patient satisfaction of pain management between groups 48 hours
Secondary 48-hour postoperative units of oral morphine consumption • To compare 48-hour postoperative units of oral morphine consumption between groups 48 hours
Secondary the incidence of nausea and/or vomiting within 48 hour of the block • To compare the incidence of nausea and/or vomiting within 48 hour of the block 48 hours
Secondary • Rebound pain on a scale of 0-10 (0=no pain 10=worst possible pain), which is the worst level of pain experienced within the 2 hours after the block wore off • Rebound pain (the worst pain in the 2 hours after the block wore off) 48 hours
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT04656834 - Hand Incision Study
Enrolling by invitation NCT04636463 - Music in Wide Awake Hand Surgery N/A
Completed NCT05343299 - Postoperative Experience of 2 WALANT-type Modes of Anesthesia Used in Ambulatory Surgery of the Upper Limb. Phase 1
Completed NCT00321425 - Ultrasound Guidance Vs. Electrical Nerve Stimulation for Infraclavicular Brachial Plexus Block N/A
Completed NCT00954928 - The Safety of Hand Surgery in the Anticoagulated Patient N/A
Completed NCT02209246 - The Effect of Feedback Regarding Illness Behavior on Patient Satisfaction in Hand Surgery N/A
Completed NCT00956683 - Dual Endpoint Nerve Stimulation Versus Ultrasound in Infraclavicular Block for Hand Surgery N/A
Completed NCT04491656 - Evaluating Clinical Outcomes for Determining the Optimal Delay to Skin Incision Under WALANT N/A
Terminated NCT00827658 - Ulnar Nerve Block for Procedural Anesthesia - Wrist Versus Palm N/A
Recruiting NCT04306666 - Early Rehabilitation After Hand or Wrist Ambulatory Surgery : How to Preserve Locomotion at Home Without Rebound Pain?
Completed NCT04189198 - A Comparison of 4% Articaine Versus 0.5%Bupivacaine for Ambulatory Surgery Under Supraclavicular Block Phase 1
Completed NCT00699244 - Comparison of Central Versus Peripheral Placement of Local Anesthetic N/A
Active, not recruiting NCT02073383 - Three Techniques for Ultrasound Guided Axillary Brachial Plexus Block N/A
Completed NCT03632304 - Local Anesthesia With Minimal Sedation and Brachial Plexus Block in Hand Surgery N/A
Completed NCT05325372 - A Comparative Study Between Infraclavicular and Axillary Blocks for Assessment of Motor Power Using Handgrip Dynamometer N/A